Search results for: 'Sorafenib'
- A3009 Sorafenib2 CitationTarget: Raf|VEGFRSummary: Raf kinases and tyrosine kinases inhibitor
- A8245 Sorafenib Tosylate1 CitationTarget: Raf|VEGFRSummary: Raf kinases and tyrosine kinases inhibitor
- L1034 DiscoveryProbe™ PI3K/Akt/mTOR Compound LibrarySummary: A unique collection of 178 PI3K/Akt/mTOR inhibitors for PI3K/Akt/mTOR signaling pathway research.
- BA1450 PK150Summary: PK150 is a Sorafenib analog.
- BA2806 SC-43Summary: SC-43, a derivative of Sorafenib, is a potent agonist with oral activity.
- BA3456 UC2288Summary: UC2288 is a novel, cell permeable and orally active attenuating reagent (with relatively selective activity against p21) based on the structural synthesis of sorafenib.